Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium

This study has been completed.

Sponsor:

Collaborator:

National Cancer Institute (NCI)

Information provided by (Responsible Party):

Eastern Cooperative Oncology Group

ClinicalTrials.gov Identifier:

NCT00053209

First received: January 27, 2003

Last updated: November 30, 2012

Last verified: November 2012

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	May 2009
Primary Completion Date:	September 2007 (Final data collection date for primary outcome measure)

Publications:

Dreicer R, Li H, Cooney MM, Wilding G, Roth BJ. Phase 2 trial of pemetrexed disodium and gemcitabine in advanced urothelial cancer (E4802) : a trial of the Eastern Cooperative Oncology Group. Cancer. 2008 May 5; [Epub ahead of print]

Li S, Dreicer R, Roth B, et al.: Phase II trial of pemetrexed disodium and gemcitabine in advanced carcinoma of the urothelium (E4802): a trial of the Eastern Cooperative Oncology Group. [Abstract] J Clin Oncol 25 (Suppl 18): A-5079, 254s, 2007.

To Top